OPTIONS IX 24 - 28 August 2016
* Earlybird registration closes 5 May *Options for the Control of Influenza Conference
Sheraton Grand Chicago Hotel, Chicago, USA.
In this, the year of our 10th anniversary, we are especially proud to announce the launch of ISIRV's premier event, the 9th in the series of Options for the Control of Influenza conferences - OPTIONS IX.
Held every 3 years, it remains the largest international conference exclusively devoted to influenza prevention, control and treatment, including seasonal flu and pandemic preparedness. The programme is well-developed and led by workgroups on Clinical Science, Public Health plus Virology and Pathogenesis. Like its predecessors, OPTIONS IX will attract leaders from global industry, top educational institutions, healthcare facilities and government agencies. Not to be missed.
For more information click on the banner above or here
Influenza Vaccine The recommended composition of influenza virus vaccines for use in the 2016-2017 northern hemisphere influenza season can be found here.
Zoonotic Influenza The update 'Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness'
can be found here.
MERS-CoV Information and links to other sources of information on this evolving situation is available through the news section
8th WHO meeting on development of influenza vaccines that induce broadly protective and long-lasting immune responses
23-24 August 2016, Chicago, USA
The meeting will gather leading experts from academic and private sector institution, and public health organizations.
For more information click here
3rd WHO Consultation on Global Action Plan for Influenza Vaccines
15-16 November 2016
The Global Action Plan for Influenza Vaccines (GAP) was launched in 2006 as a 10-year initiative to address the anticipated shortfall in vaccine supply in the event of a pandemic. The third and final consultation of GAP will be held in Geneva, Switzerland on 15-16 November 2016. In the lead-up to the closure of the GAP and the final consultation, WHO is soliciting an online questionnaire from key stakeholders. The questionnaire is designed to measure stakeholders views on progress and remaining needs under the three objectives of the GAP. Responses will be used to feed into the development of the agenda for the final consultation.
For more information click here
The ISIRV Journal, Influenza and other Respiratory Viruses, is now published in an Online Only format. No printed issue will be produced but authors will still be able to order offprints of their own articles.
ISIRV members will receive a 10% discount for articles submitted. Contact firstname.lastname@example.org for the code.
The inaugural conference organised by the Respiratory Pathogens special interest group took place on 2- 4 September 2015 in Singapore.
A report of the IMRP conference can be found here and resources from that meeting will be made available shortly.
The 4th ISIRV-AVG Conference - Novel Antiviral Therapies for Influenza and Other Respiratory Viruses : Bench to Bedside - took place 2 - 4 June 2015 in Austin, USA.
A workshop on Next Generation Sequencing of Viruses was held on 20 - 21 May 2015 in Paris, France. Resources from that meeting are available in the Members' area of the website. A report of the meeting can be found here